This study provides first evidence that genetic inactivation of DNA-PKcs, frequently deregulated in advanced liver cancer, enhanced sensitivity of liver cancer cells to proton beam therapy via induction of apoptotic death. The gene discussed is PRKDC; the disease is liver cancer.